Article Information
History
- May 2, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jihad Mallat, MD, Msc1,*,
- Fadi Hamed, MD1,
- Maher Balkis, MD2,
- Mohamed A. Mohamed, MD3,
- Mohamad Mooty, MD2,
- Asim Malik, MD2,
- Ahmad Nusair, MD2 and
- Maria-Fernanda Bonilla, MD2
- 1Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
- 2Infectious Disease, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
- 3Hospital Medicine, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE
- ↵*Corresponding author, Jihad Mallat, MD, Msc, Critical Care Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, PO Box 112412, Abu Dhabi, UAE, mallatjihad{at}gmail.com
Posted May 02, 2020.
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
